The American Society for Microbiology (ASM) is holding the 108th General Meeting in Boston, MA, from
June 1-5, 2008. bioMérieux is excited to offer a variety of educational events that will teach you how to provide better patient care while improving the clinical value of your lab. In addition to our traditional ASM events, we have partnered with clinical laboratories throughout the U.S. to deliver poster presentations of our research on highly drug-resistant organisms.
Experience The Fully Automated Lab
We are excited to share with you the ultimate integrated experience at the ASM 108th General Meeting. We will show you the benefits of our integrated solutions by bringing the microbiology lab to you. Visit us at booth #731 and experience the Automated Microbiology Lab, where you
will learn how to enhance, automate and make the most
of your lab.
In-Booth Knowledge Forums
Please visit bioMérieux booth #731 June 2nd and June 3rd between
11:15am and 1:45pm to listen to your peers discuss the following topics:
Hudson Garrett, PDI – Chlorahexadine and Safe Blood Culture Collection
Christine Ginnochio, Ph.D, North Shore LIJ Health System, – Molecular Automation
John Glasson, Bioscience Consultant, LabTech Systems –
Automated Streaking
Janet Hindler, MCLS, MT(ASCP), F(AMM), UCLA Medical Center – CLSI Updates: Antibiograms
Davise Larone, Ph.D, D(ABMM), F(AMM), Cornell University –
Galactomann & Beta-Glucan (Non-Culture Based Diagnostic Tests for Fungi)
Margie Morgan, Ph.D, Chief Microbiologist, Cedar-Sinai Medical Center – Managing Blood Stream Infections
WHAT: bioMérieux is going back to the basics at our
30th Annual Microbiology User Group. An evening
hosted by key industry notables will provide you the opportunity to learn about antibiotic overuse, rapid results and the trends in lab automation.
5:00-6:00 p.m.
Registration, Cocktail and Dinner
6:00-6:05 p.m.
Welcome, Herb Steward, Executive Vice President and General Manager, bioMérieux North America
George Drusano, Ordway Research – The Lab’s Role in Getting Relevant Results Interpretable Data to the Clinical
Susan Foster, APUA – Economic Impact of the Overuse
of Antibiotics, The Trends in Lab Automation
Additional Posters at ASM
bioMérieux and Washington University School of Medicine (St. Louis, MO) will also be presenting two posters at ASM. Look for “Daptomycin and Telavancin MIC Tests for Gram-Positive Organisms with the VITEK 2 Systems” and “Ceftobiprole, Clindamycin, Doripenem, Faropenem, and Televancin MIC Tests for Streptococcus pneumoniae with the VITEK 2 Systems.”
bioMérieux Appreciates YOU!
Each year bioMérieux kicks off ASM with a special Customer Appreciation Party. Join us this year for an exciting evening at Fenway Park, Monday, June 2 at 7:30 p.m. Start the night off with an ice-cold beverage in an authentic Boston Red Sox stadium cup! Next, you may want to go check out the Green Monster or visit one of the many buffet stations placed around the Executive Suite.
Once you get your energy off the fantastic food, go and visit the actual Red Sox batting cage and take a cut like the World Series Professionals! When you hit your homerun, you will then have the chance to go and meet one of Boston’s alumni players.
Now that your arms have had a workout, then you can take a tour of the stadium and locker rooms or go and snack
on some delicious desserts!
When you want to move back to the Suite you can dance the night away with one of Boston’s favorite bands!
If that isn’t enough…you will leave with an authentic bioMérieux/Boston Red Sox ticket stub to remember the evening…
Reducing the emergence and spread of drug-resistant organisms continues to pose a major challenge to clinical laboratories today. To help combat these emerging disease threats, bioMérieux established the BORIS (bioMérieux Organism Resistance Initiative Surveillance) network to collect and study drug-resistant organisms from participating U.S. clinical laboratories. In collaboration with our network laboratories, we will present two posters of original research from BORIS at this year’s ASM General Meeting in Boston.
Both presentations will address challenges in susceptibility testing of organisms resistant to multiple antimicrobial classes and detection of emerging resistance mechanisms such as AmpC, KPC and metallo-ß-lactamases (MBL). The posters will include our research of the multi-drug resistant organisms Acinetobacter baumannii (AB) and Pseudomonas aeruginosa (PA).
The first study evaluated the prevalence of MBLs in clinical isolates of multi-drug resistant AB. Levels of MBL-producing AB have been increasing in nosocomial infections worldwide, but only a few cases have been reported in the U.S. Results indicate that AB isolates collected from four U.S. laboratories show an overall high resistance to carbapenems.
The second study evaluated multi-drug resistant PA, a common cause of healthcare-associated infections (HAI). Clinical isolates were collected from three U.S. laboratories and tested for the presence of various resistance mechanisms. All PA isolates show moderate to high levels of resistance to most antibiotics tested, with 50 percent or more of isolates resistant to carbapenems. We hope you plan to attend both presentations, where we will discuss how you can use our research to protect your lab from these emerging threats.
The American Society for Microbiology (ASM) is holding the 108th General Meeting in Boston, MA, from
June 1-5, 2008. bioMérieux is excited to offer a variety of educational events that will teach you how to provide better patient care while improving the clinical value of your lab. In addition to our traditional ASM events, we have partnered with clinical laboratories throughout the U.S. to deliver poster presentations of our research on highly drug-resistant organisms.
In-Booth Knowledge Forums
Both presentations will address challenges in susceptibility testing of organisms resistant to multiple antimicrobial classes and detection of emerging resistance mechanisms such as AmpC, KPC and metallo-ß-lactamases (MBL). The posters will include our research of the multi-drug resistant organisms Acinetobacter baumannii (AB) and Pseudomonas aeruginosa (PA).
